Skip to main content
. Author manuscript; available in PMC: 2015 Nov 6.
Published in final edited form as: J Invest Dermatol. 2014 Aug 7;135(1):102–109. doi: 10.1038/jid.2014.271

Figure 3. IgE reactivity of rDer p 11.

Figure 3

(a) Comparison of the intensity of IgE recognition of rDer p 11, rDer p 2, and BSA (negative control) as tested by dot blot with sera from mite-allergic patients (1–20), a nonallergic individual (NC), and with buffer alone (BC). (b) Prevalence of IgE reactivity to rDer p 11 and rDer p 2 (y axis: percentages of reactive patients) in different populations of house dust mite-allergic patients (x axis: Austria: n = 47; France: n = 38; Italy: n = 67; Sweden: n = 52; Zimbabwe: n = 34).